Physician profile
Nancy C Braddock
NPI 1437275252
$2,975.42
in general payments reported to CMS, 2019-2025
24 companies · $975 in 2025
The $975 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $599 · 2022: $669 · 2023: $113 · 2024: $620 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $963.89 | 2021-2025 | |
| Janssen Biotech, INC. | $595.28 | 2022-2025 | Tremfya, Stelara, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $248.97 | 2021-2025 | Entyvio, Eohilia, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.39 | 2021-2023 | Xifaxan |
| Neurocrine Biosciences, INC. | $124.99 | 2024 | Ingrezza |
| Genzyme Corporation | $123.27 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $111.76 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $103.33 | 2021-2022 | |
| Braintree Laboratories, INC. | $74.10 | 2021-2022 | |
| Celltrion USA INC. | $67.60 | 2025 | Vegzelma |
| Gilead Sciences, INC. | $65.41 | 2021 | |
| Evoke Pharma, INC. | $60.43 | 2022 | |
| Ardelyx, INC. | $58.51 | 2024-2025 | Ibsrela |
| Ipsen Biopharmaceuticals, INC | $46.67 | 2025 | Iqirvo |
| Vivus LLC | $31.47 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $28.29 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $21.54 | 2021 | |
| Pfizer INC. | $20.29 | 2023 | |
| Medtronic, INC. | $18.24 | 2022 | |
| Exact Sciences Corporation | $17.67 | 2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $16.48 | 2022 | |
| Intercept Pharmaceuticals, INC. | $16.13 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.37 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Braddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.